LFB USA Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • LFB USA's estimated annual revenue is currently $16.1M per year.(i)
  • LFB USA's estimated revenue per employee is $155,000

Employee Data

  • LFB USA has 104 Employees.(i)
  • LFB USA grew their employee count by 8% last year.

LFB USA's People

NameTitleEmail/Phone
1
SVP, QualityReveal Email/Phone
2
VP Industrial Planning and Supply ManagementReveal Email/Phone
3
VP, Finance & ITReveal Email/Phone
4
Director, Regulatory AffairsReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
Sr. Director FinanceReveal Email/Phone
7
Director, QA ComplianceReveal Email/Phone
8
Health And Safety OfficerReveal Email/Phone
9
QA Manager DocumentationReveal Email/Phone
10
Manager Technical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is LFB USA?

Company Profile\r\n\r\nLFB USA, Inc. is a privately held biotechnology company in the Boston, Massachusetts area with headquarters and laboratories in Framingham, MA and production operations in Charlton, MA. LFB USA is a company within the LFB Group. LFB USA provides development, manufacturing and services to LFB S.A., its sister company rEVO Biologics, and other partners. \r\n\r\nOne of the lead projects of LFB S.A. is the recombinant human Factor FVIIa (LR769) program. LFB USA is responsible for the upstream manufacturing of the recombinant protein and the Clinical and Regulatory aspects of the program. LR769 is currently being evaluated in a Phase 3 study in adults with congenital hemophilia A or B with inhibitors. \r\n\r\nLFB USA’s principal goal is to advance medical care by utilizing its proprietary technology to develop its own programs and assist its partners by providing a full range of services. \r\n\r\nLFB USA is currently looking for motivated scientific, business and healthcare professionals with an entrepreneurial spirit.\r\n\r\nFor more information about LFB USA please visit www.lfb-usa.com\r\n\r\nCompany Background\r\n\r\nLFB USA, Inc. was formed as a subsidiary of LFB Biotechnologies in April, 2014 as the result of a carve-out of rEVO Biologics, Inc.

keywords:N/A

N/A

Total Funding

104

Number of Employees

$16.1M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LFB USA News

2022-04-19 - Fibrin Market Size 2022-2030| Key Players – Csl Behring, Baxter ...

Fibrin Market Size 2022-2030| Key Players – Csl Behring, Baxter, Johnson & Johnson (ethicon), Lfb Group. Market Size And Forecast. New Jersey, USA,- The...

2022-04-19 - Human Fibrinogen Concentrate Market Forecast 2022-2030| Key ...

... Forecast 2022-2030| Key Players – CSL Behring, LFB Group, Shanghai RAAS, ... New Jersey, USA,- The research study presented here is a very detailed and...

2022-04-17 - Antithrombin Market Research Report by Formulation, Source, Type, Route, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

The United States is further studied across California, Florida, Illinois, ... Lee Biosolutions, Inc, LFB USA, Machaon Diagnostics, Inc.,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.8M1057%N/A
#2
$28.6M1068%N/A
#3
$22.7M1132%N/A
#4
N/A11577%N/A
#5
$38.3M11622%N/A